Replacement Device Credits: Following the Credit Memo Back to Medicare

A medical device replacement credit can reduce Medicare’s payment for the hospital stay or outpatient procedure that includes the replacement. The manufacturer supplies a free device or grants a qualifying credit, and the hospital must account for it in its Medicare billing. If you work in supply chain, accounts payable or revenue cycle, you may see the credit arrive while the claim stays unchanged. The hospital’s cost has fallen. Medicare and taxpayers may still be paying for a cost the hospital no longer bears.

How Does Reimbursement Work for Medical Devices?

Medicare usually includes an implanted device in its bundled payment for the hospital stay or procedure. The hospital buys the implant, while the physician may choose or strongly influence which device goes into the patient. The purchasing decision, clinical decision and government payment meet in the same episode of care.

For inpatient care, Medicare pays through diagnosis-related groups. For hospital outpatient care, it pays through ambulatory payment classifications. A device can have a code and a charge line while its cost remains packaged into the procedure payment.

That packaging is why a replacement credit matters beyond the purchasing department. Medicare’s payment already includes a device component. A free replacement or a qualifying credit changes what the hospital paid to provide the replacement, and the payment rules require an adjustment for covered claims.

The cardiac-device billing guidance from the Centers for Medicare & Medicaid Services describes replacements involving pacemakers, defibrillators and their electrical leads. Defects, recalls, battery depletion and mechanical complications can lead to replacement under a manufacturer’s warranty. A recall notice starts one part of that story. The manufacturer’s credit and the hospital bill tell the financial part.

Where the Credit Memo Meets the Claim

The evidence connects the device removed, the replacement supplied, the manufacturer’s warranty decision and the hospital’s billing. We trace that connection with the people who know how the purchase and replacement actually happened.

The original invoice and purchase record identify what the hospital bought. The implant and explant records connect that purchase to the device used and later removed. The warranty terms and any return correspondence help explain what the manufacturer was asked to provide when the device came out.

From there, the manufacturer’s decision and credit memo show whether a credit was granted, for how much and to whom. The replacement invoice supplies the cost against which the credit may need to be measured. Accounts payable and patient accounting then answer different questions: did the hospital recognize the credit, and did its Medicare billing reflect it?

We connect those records to the original and replacement episodes, the submitted claims and any later adjustments. If a qualifying credit arrives after Medicare has paid, we look for the corresponding claim adjustment. The credit’s arrival and the claim’s adjustment history show whether billing caught up.

There are distinct places for the money to stop. The manufacturer-side allegations concern credits the purchaser never received. The hospital-side inquiry concerns a reportable credit that arrived but never reached the claim. The first inquiry starts with the warranty promise and the manufacturer’s decision. The second starts with the credit already received and the hospital’s response.

The missing handoff is visible in the North Mississippi Medical Center audit. Hospital officials told the Health and Human Services inspector general that the hospital was unaware it had received the credits behind the questioned inpatient and outpatient claims. The manufacturer had issued the credit. The hospital’s billing had not caught up.

Which Medicare Payment Rules Apply?

The care setting, replacement cost and date of service determine which credit-reporting rule applies. Inpatient hospital payment, hospital outpatient payment and ambulatory surgical center payment have separate instructions.

Inpatient Credits and the 50% Rule

For inpatient care, a partial credit triggers the payment adjustment when it reaches at least 50% of the replacement device’s cost. The payment adjustment also covers devices supplied without cost or with full credit, and applies to specified diagnosis-related groups in which implantation determines the payment classification. The inpatient regulation applies to discharges beginning October 1, 2007.

In the fiscal year 2012 rule, Medicare made clear that the partial-credit threshold uses the replacement device’s cost. The old implant’s invoice and the new implant’s invoice answer different questions. Comparing the credit with the wrong purchase price can change whether it appears to cross the threshold.

Medicare’s fiscal year 2026 inpatient update repeats that replacement-cost test and points to the year’s list of covered MS-DRGs. The relevant list belongs beside the claim date. The policy applies to specified payment groups, rather than every hospital discharge involving a device.

The inpatient claims manual says Medicare deducts the partial or full credit reported under value code FD from the final inpatient payment for a covered MS-DRG.

Hospital Outpatient Credits and the Device Offset

The June 2026 Medicare guidance measures a qualifying outpatient partial credit against the replacement device’s cost.

For covered outpatient procedures, Medicare cuts its payment by the credit, capped at the device offset. The offset is the device amount used in the procedure’s payment adjustment. The hospital’s credit memo supplies one figure, and the applicable payment classification supplies the other.

The charge line matters too. Medicare’s guidance says a no-cost outpatient device should carry a $0 charge. When a billing system requires a charge, it allows a token amount, such as $1. A free device still needs an accurate place on the bill.

FB, FC and FD Depend on the Setting and Date

Before January 1, 2014, hospital outpatient claims used modifier FB for a device supplied without cost or with full credit, and FC for a qualifying partial credit. The modifiers attached to the procedure code. Beginning on that date, the outpatient claims manual replaced those hospital reporting requirements with value code FD, which carries the credit amount.

Condition code 49 identifies replacement before the expected end of the product’s life because of a suspected malfunction. Condition code 50 identifies replacement following a recall. Those descriptions distinguish why the device was supplied from how much credit the hospital received.

The outpatient claims manual still requires FB and FC on ambulatory surgical center claims. The hospital’s switch to FD did not apply to those centers.

Medical Device Replacement Credit Audits Show the Missing Handoff

Medical device replacement credit audits compare the manufacturer’s credit information with hospital records and Medicare payments.

North Mississippi’s Credits Were Missing From Its Bills

In its December 2016 report, the inspector general reviewed a sample drawn from claims identified as potentially at risk for billing errors. One of 110 inpatient claims involved an unreported device credit, producing a $6,400 overpayment. Two of 127 outpatient claims involved full credits without the required modifier and reduced charges, producing $24,095 in overpayments.

For both sets of device-credit errors, hospital officials said they had been unaware of the credits. The hospital agreed with those findings and said it had corrected its policies, audit measures and staff training. The inspector general recommended refunds, review of similar overpayments and stronger controls.

The audit method explains how the mismatch became visible. The inspector general obtained known cardiac-device credit information from manufacturers, examined paid claims, checked whether claims had been canceled or adjusted, and reviewed itemized bills and medical records. The comparison joined information held on opposite sides of the transaction.

The National Findings Cover Different Questions

The inspector general’s national cardiac-device credit review found 3,233 noncompliant claims among 6,558 reviewed across 911 hospitals, with $33,095,068 in potential overpayments. These figures measure a reporting problem across hospitals, while the North Mississippi report shows how a specific hospital explained its missed credits.

The national review also cited an earlier inspector general estimate of $1.5 billion in Medicare costs associated with recalled and prematurely failed devices during 2005 through 2014.

When CMS’s Manual and Regulation Disagreed

The inspector general’s November 2020 review examined 4,637 outpatient claims from 2016 through 2018 that already reported credits. It estimated overpayments of as much as $35.4 million because Medicare’s manual and regulation called for different payment reductions.

The conflict began in 2014. The manual used the credit amount, capped at the device offset. The inspector general read the regulation as requiring the full offset for no-cost or full-credit replacements and half the offset for qualifying partial credits. Contractors followed the manual. In the inspector general’s view, the agency had given the people processing the claims instructions that conflicted with its own rule.

The inspector general recommended recovering overpayments and resolving the conflict. CMS disagreed with the recovery recommendations and challenged the estimate’s assumption that all reported credits were full credits. It amended the outpatient regulation on December 29, 2020, in the rule for calendar year 2021.

Guidant and St. Jude’s Withheld-Credit Allegations

The manufacturer-side cases concern warranty benefits that allegedly never reached the purchaser. The government alleged both manufacturers promoted credits as a reason to buy their devices.

Guidant agreed to a $9.25 million civil settlement in September 2011 over allegations that it knowingly failed to grant warranty credits and rebates for explanted pacemakers and defibrillators. The Justice Department alleged that Guidant promoted the products’ longevity and the generous credits available if replacement became necessary, while knowing that appropriate credits went ungranted in many eligible cases.

The government described separate payment consequences. Guidant allegedly sent inflated replacement invoices to VA hospitals and Defense facilities. It also allegedly sent inflated invoices to private hospitals, causing them to overstate device costs on their hospital cost reports and increasing Medicare payments. The Medicare allegation reached the cost report, a different document from an individual replacement claim.

St. Jude Medical agreed to a $3.65 million civil settlement in May 2012. The government alleged that it advertised generous warranty credits but knowingly failed to grant appropriate credits when covered devices were replaced. The resulting invoices allegedly overstated replacement costs for the Departments of Veterans Affairs and Defense.

The alleged sales promise and the alleged billing practice pulled in opposite directions. A credit helped sell the original device. Withholding it increased what the purchaser paid when that device needed replacing.

Both civil settlements followed whistleblower cases. For an insider at a manufacturer, the warranty terms, sales representations, replacement records and credit decisions connect that promise to the amount charged.

What Evidence Is Needed to Prove Fraud?

The evidence needs to connect the credit decision to the federal health care payment and to what the people responsible knew. A manufacturer employee may understand why eligible replacements received no credit. A hospital employee may know why a credit already posted in accounts payable never reached patient accounting.

A 2020 analysis in the Journal of Forensic and Investigative Accounting, A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, explains why the claim for payment is central to False Claims Act liability. It also examines knowledge, deliberate ignorance and reckless disregard. Here, that means tying the missing credit to the bill and to who knew.

There is a revealing limit in the outpatient claims manual: it requires the condition code when FD is present. That check starts after the credit has been disclosed. We therefore look beyond the claim fields to the manufacturer’s credit record and the hospital’s handling of it.

The people who saw the credit, the instructions passed between departments and the claim’s adjustment history help explain where the handoff failed. We work through those records with you to build the healthcare fraud case around the actual replacement and payment.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Can See Where the Credit Stopped

If you know a manufacturer withheld warranty credits or a hospital received them without changing its Medicare bills, speak with our whistleblower experts about where the credit stopped. We build the case with you across the warranty decision, hospital accounts and government payment, and bring in medical device whistleblower lawyers who understand hospital reimbursement. We stay beside you from that first conversation through the case.